世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metastatic Melanoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4498
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、転移性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的化学療法、標的免疫療法、標的MAPキナーゼ療法、抗血管新生療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・転移性黒色腫治療の市場動向
・企業の競争状況、市場シェア
・転移性黒色腫治療の種類別市場規模と予測2016-2027（標的化学療法、標的免疫療法、標的MAPキナーゼ療法、抗血管新生療法、その他）
・転移性黒色腫治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他）
・転移性黒色腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・転移性黒色腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・転移性黒色腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・転移性黒色腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・転移性黒色腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott、Roche、GSK、Agilent Technologies、Novartis、Merck、Sanofi、Pfizer、Bristol-Myer Squibb）
・結論

Market Analysis and Insights: Global Metastatic Melanoma Treatment Market
The global Metastatic Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Melanoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Melanoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Melanoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Melanoma Treatment market.

Global Metastatic Melanoma Treatment Scope and Market Size
Metastatic Melanoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Melanoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Chemotherapy
Targeted Immunotherapy
Targeted MAP-Kinase Therapy
Anti-Angiogenesis Therapy
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Roche
GSK
Agilent Technologies
Novartis
Merck
Sanofi
Pfizer
Bristol-Myer Squibb

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Melanoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Chemotherapy
1.2.3 Targeted Immunotherapy
1.2.4 Targeted MAP-Kinase Therapy
1.2.5 Anti-Angiogenesis Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Metastatic Melanoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastatic Melanoma Treatment Market Perspective (2016-2027)
2.2 Metastatic Melanoma Treatment Growth Trends by Regions
2.2.1 Metastatic Melanoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Melanoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Melanoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Melanoma Treatment Industry Dynamic
2.3.1 Metastatic Melanoma Treatment Market Trends
2.3.2 Metastatic Melanoma Treatment Market Drivers
2.3.3 Metastatic Melanoma Treatment Market Challenges
2.3.4 Metastatic Melanoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastatic Melanoma Treatment Players by Revenue
3.1.1 Global Top Metastatic Melanoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Melanoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Melanoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Melanoma Treatment Revenue
3.4 Global Metastatic Melanoma Treatment Market Concentration Ratio
3.4.1 Global Metastatic Melanoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Melanoma Treatment Revenue in 2020
3.5 Metastatic Melanoma Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Melanoma Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Melanoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Melanoma Treatment Breakdown Data by Type
4.1 Global Metastatic Melanoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Melanoma Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Melanoma Treatment Breakdown Data by Application
5.1 Global Metastatic Melanoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Melanoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metastatic Melanoma Treatment Market Size (2016-2027)
6.2 North America Metastatic Melanoma Treatment Market Size by Type
6.2.1 North America Metastatic Melanoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Melanoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Melanoma Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Melanoma Treatment Market Size by Application
6.3.1 North America Metastatic Melanoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Melanoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Melanoma Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Melanoma Treatment Market Size by Country
6.4.1 North America Metastatic Melanoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Melanoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metastatic Melanoma Treatment Market Size (2016-2027)
7.2 Europe Metastatic Melanoma Treatment Market Size by Type
7.2.1 Europe Metastatic Melanoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Melanoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Melanoma Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Melanoma Treatment Market Size by Application
7.3.1 Europe Metastatic Melanoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Melanoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Melanoma Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Melanoma Treatment Market Size by Country
7.4.1 Europe Metastatic Melanoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Melanoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metastatic Melanoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Melanoma Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Melanoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Melanoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Melanoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Melanoma Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Melanoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Melanoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Melanoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Melanoma Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Melanoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Melanoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metastatic Melanoma Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Melanoma Treatment Market Size by Type
9.2.1 Latin America Metastatic Melanoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Melanoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Melanoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Melanoma Treatment Market Size by Application
9.3.1 Latin America Metastatic Melanoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Melanoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Melanoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Melanoma Treatment Market Size by Country
9.4.1 Latin America Metastatic Melanoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Melanoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metastatic Melanoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Melanoma Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Melanoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Melanoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Melanoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Melanoma Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Melanoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Melanoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Melanoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Melanoma Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Melanoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Melanoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Metastatic Melanoma Treatment Introduction
11.1.4 Abbott Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Melanoma Treatment Introduction
11.2.4 Roche Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Metastatic Melanoma Treatment Introduction
11.3.4 GSK Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Metastatic Melanoma Treatment Introduction
11.4.4 Agilent Technologies Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Melanoma Treatment Introduction
11.5.4 Novartis Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Metastatic Melanoma Treatment Introduction
11.6.4 Merck Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Metastatic Melanoma Treatment Introduction
11.7.4 Sanofi Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Metastatic Melanoma Treatment Introduction
11.8.4 Pfizer Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Bristol-Myer Squibb
11.9.1 Bristol-Myer Squibb Company Details
11.9.2 Bristol-Myer Squibb Business Overview
11.9.3 Bristol-Myer Squibb Metastatic Melanoma Treatment Introduction
11.9.4 Bristol-Myer Squibb Revenue in Metastatic Melanoma Treatment Business (2016-2021)
11.9.5 Bristol-Myer Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastatic Melanoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Chemotherapy
Table 3. Key Players of Targeted Immunotherapy
Table 4. Key Players of Targeted MAP-Kinase Therapy
Table 5. Key Players of Anti-Angiogenesis Therapy
Table 6. Key Players of Others
Table 7. Global Metastatic Melanoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metastatic Melanoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Metastatic Melanoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Metastatic Melanoma Treatment Market Share by Regions (2016-2021)
Table 11. Global Metastatic Melanoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Metastatic Melanoma Treatment Market Share by Regions (2022-2027)
Table 13. Metastatic Melanoma Treatment Market Trends
Table 14. Metastatic Melanoma Treatment Market Drivers
Table 15. Metastatic Melanoma Treatment Market Challenges
Table 16. Metastatic Melanoma Treatment Market Restraints
Table 17. Global Metastatic Melanoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Metastatic Melanoma Treatment Market Share by Players (2016-2021)
Table 19. Global Top Metastatic Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Melanoma Treatment as of 2020)
Table 20. Ranking of Global Top Metastatic Melanoma Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Metastatic Melanoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Metastatic Melanoma Treatment Product Solution and Service
Table 24. Date of Enter into Metastatic Melanoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Metastatic Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Metastatic Melanoma Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Metastatic Melanoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Metastatic Melanoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Metastatic Melanoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Metastatic Melanoma Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Metastatic Melanoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Metastatic Melanoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Metastatic Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Metastatic Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Metastatic Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Metastatic Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Metastatic Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Metastatic Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Metastatic Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Metastatic Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Metastatic Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Metastatic Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Metastatic Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Metastatic Melanoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Metastatic Melanoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Metastatic Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Metastatic Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Metastatic Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Metastatic Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Metastatic Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Metastatic Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Metastatic Melanoma Treatment Product
Table 67. Abbott Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Metastatic Melanoma Treatment Product
Table 72. Roche Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 73. Roche Recent Development
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Metastatic Melanoma Treatment Product
Table 77. GSK Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 78. GSK Recent Development
Table 79. Agilent Technologies Company Details
Table 80. Agilent Technologies Business Overview
Table 81. Agilent Technologies Metastatic Melanoma Treatment Product
Table 82. Agilent Technologies Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 83. Agilent Technologies Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Metastatic Melanoma Treatment Product
Table 87. Novartis Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Metastatic Melanoma Treatment Product
Table 92. Merck Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 93. Merck Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Metastatic Melanoma Treatment Product
Table 97. Sanofi Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 98. Sanofi Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Bristol-Myer Squibb Company Details
Table 104. Bristol-Myer Squibb Business Overview
Table 105. Bristol-Myer Squibb Metastatic Melanoma Treatment Product
Table 106. Bristol-Myer Squibb Revenue in Metastatic Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 107. Bristol-Myer Squibb Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Melanoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Targeted Chemotherapy Features
Figure 3. Targeted Immunotherapy Features
Figure 4. Targeted MAP-Kinase Therapy Features
Figure 5. Anti-Angiogenesis Therapy Features
Figure 6. Others Features
Figure 7. Global Metastatic Melanoma Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Metastatic Melanoma Treatment Report Years Considered
Figure 13. Global Metastatic Melanoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Metastatic Melanoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Metastatic Melanoma Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Metastatic Melanoma Treatment Market Share by Regions (2022-2027)
Figure 17. Global Metastatic Melanoma Treatment Market Share by Players in 2020
Figure 18. Global Top Metastatic Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Melanoma Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Metastatic Melanoma Treatment Revenue in 2020
Figure 20. Global Metastatic Melanoma Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Metastatic Melanoma Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Metastatic Melanoma Treatment Market Share by Type (2016-2027)
Figure 24. North America Metastatic Melanoma Treatment Market Share by Application (2016-2027)
Figure 25. North America Metastatic Melanoma Treatment Market Share by Country (2016-2027)
Figure 26. United States Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Metastatic Melanoma Treatment Market Share by Type (2016-2027)
Figure 30. Europe Metastatic Melanoma Treatment Market Share by Application (2016-2027)
Figure 31. Europe Metastatic Melanoma Treatment Market Share by Country (2016-2027)
Figure 32. Germany Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Metastatic Melanoma Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Metastatic Melanoma Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Metastatic Melanoma Treatment Market Share by Region (2016-2027)
Figure 42. China Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Metastatic Melanoma Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Metastatic Melanoma Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Metastatic Melanoma Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Metastatic Melanoma Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Metastatic Melanoma Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Metastatic Melanoma Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Metastatic Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 64. Agilent Technologies Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 69. Bristol-Myer Squibb Revenue Growth Rate in Metastatic Melanoma Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Metastatic Uveal Melanoma Thereapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5859 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、転移性ブドウ膜メラノーマ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リンゴ酸スニチニブ、硫酸ビンクリスチンリポソーム、LY-2801653、酢酸ソトラスタウリン、その他）、用途別市場規模（病...

世界の転移性悪性黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5857 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、転移性悪性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、標的療法、その他）、用途別市場規模（病院、医療研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のブドウ膜黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Uveal Melanoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5009 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ブドウ膜黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（毛様体黒色腫、虹彩黒色腫、脈絡膜黒色腫）、用途別市場規模（病院、眼科クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4496 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、転移性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の転移性結腸直腸癌治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4497 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、転移性結腸直腸癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科、化学療法）、用途別市場規模（病院、クリニック、がん研究センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5856 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、転移性骨がん薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年）

Global Medication Treatment of Metastatic Bone Disease Market Size, Status and Forecast 2021-2027
QFJ1-5846 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、転移性骨疾患薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の転移性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5858 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、転移性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単体、複合、単体/複合）、用途別市場規模（病院、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の悪性黒色腫治療市場規模・現状・予測（2021年-2027年）

Global Malignant Melanoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4459 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、悪性黒色腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科療法、放射線療法、化学療法、生物学的療法/標的療法）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模...

世界の転移性悪性黒色腫治療市場規模・現状・予測（2021年-2027年） Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
転移性悪性黒色腫療法のグローバル市場：規模・現状・予測2019-2025 Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …
世界の転移性ブドウ膜メラノーマ治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…